A detailed history of Gts Securities LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Gts Securities LLC holds 8,001 shares of ALKS stock, worth $192,824. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,001
Holding current value
$192,824
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$26.4 - $32.56 $211,226 - $260,512
8,001 New
8,001 $216,000
Q3 2023

Nov 15, 2023

BUY
$27.17 - $31.97 $223,962 - $263,528
8,243 Added 27.6%
38,106 $1.07 Million
Q2 2023

Aug 15, 2023

BUY
$28.34 - $33.63 $846,317 - $1 Million
29,863 New
29,863 $935 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $3.96B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.